IL0011595993
© PR Newswire
08.01.2026
INMD
LISTED
NASDAQ
InMode to Report Fourth Quarter & Full Year 2025 Financial Results and Hold Conference Call on February 10, 2026, Expects Q4 Revenue Between $103.6M-$103.8M
News Preview
Conference call to be held on Tuesday, February 10, 2026, at 8:30 a.m. Eastern TimeYOKNEAM, Israel, Jan. 8, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results for the fourth quarter and full year of 2025 before the Nasdaq ma...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
INMD
LISTED
NASDAQ
InMode Appoints Michael Dennison as President of North America
News Preview
IRVINE, Calif., Nov. 3, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, has appointed Michael Dennison, most recently Vice President of Sales, as President of North America. ...
Themefolio
Profiler
Peergroup
© PR Newswire
30.10.2025
INMD
LISTED
NASDAQ
InMode to Participate in Upcoming Investor Conferences
News Preview
YOKNEAM, Israel, Oct. 30, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation in the following investor conferences in November:
UBS...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© PR Newswire
09.10.2025
INMD
LISTED
NASDAQ
InMode to Report Third Quarter 2025 Financial Results and Hold Conference Call on November 5, Expects Q3 Revenue Between $92.5M-$93.0M, Reiterates FY 2025 Guidance Between $365M-$375M
News Preview
Conference call to be held on Wednesday, November 5, 2025, at 8:30 a.m. Eastern Time
YOKNEAM, Israel, Oct. 9, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results for the thir...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
09.09.2025
INMD
LISTED
NASDAQ
DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Return Capital to the Shareholders
News Preview
Believes the Board Should Approve and Execute a 10% Buyback in Q4 2025 and Another 10% Buyback in Q1 2026
Maintains Board Has Legal and Fiduciary Duty to Act in Best Interests of Shareholders
MIAMI, Sept. 9, 2025 /PRNewswire/ -- DOMA Perpetual Capital Management LLC, a significant stockholder of InMode Ltd. (NYSE: INMD) ("InMode"), today sent a...
Themefolio
Profiler
Peergroup
© PR Newswire
02.09.2025
INMD
LISTED
NASDAQ
InMode to Present at Baird 2025 Global Healthcare Conference
News Preview
YOKNEAM, Israel, Sept. 2, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Yair Malca, Chief Financial Officer will present in-person at the Baird 2025 Global Healthcare Conference in New York on Sept. 10, 2025.
The fireside chat, moderated by Jeff Johnson, Senio...
Themefolio
Profiler
Peergroup
© PR Newswire
30.07.2025
INMD
LISTED
NASDAQ
InMode Reports Second Quarter 2025 Financial Results: Quarterly Revenue of $95.6 Million, 80% Gross Margins
News Preview
YOKNEAM, Israel, July 30, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the second quarter ended June 30, 2025.
Second Quarter 2025 Highlights:
Quarterly GAAP revenues of $95.6 million, compared to $86.4 million in t...
Themefolio
Profiler
Peergroup
© PR Newswire
10.07.2025
INMD
LISTED
NASDAQ
InMode to Report Second Quarter 2025 Financial Results and Hold Conference Call on July 30, Expects Q2 Revenue Between $95.4M-$95.5M, Decreases Full Year 2025 Revenue Guidance to be Between $365M-$375M
News Preview
Conference call to be held on Wednesday, July 30, 2025, at 8:30 a.m. Eastern Time
YOKNEAM, Israel, July 10, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results for the second quarter 2025 before the Nasdaq market opens on We...
Themefolio
Profiler
Peergroup
© PR Newswire
28.05.2025
INMD
LISTED
NASDAQ
InMode Response Letter to DOMA by Moshe Mizrahy, CEO, Dated May 28, 2025
News Preview
YOKNEAM, Israel, May 28, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today sent a letter to DOMA Perpetual Capital Management LLC ("DOMA") CEO and CIO Pedro Escudero in response to issues presented in his public letter dated May 9, 2025.
The letter can be viewed here
T...
Themefolio
Profiler
Peergroup
© PR Newswire
20.05.2025
INMD
LISTED
NASDAQ
InMode Announces Health Canada Certification of the IgniteRF Platform with the New QuantumRF Technology
News Preview
YOKNEAM, Israel, May 20, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, is pleased to announce Health Canada certification of IgniteRF, an advanced platform offering a comprehensive suite of minimally invasive radiofrequency solutions for the face and body.
IgniteRF is equipped...
Themefolio
Profiler
Peergroup
© PR Newswire
09.05.2025
INMD
LISTED
NASDAQ
DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Resume Share Repurchase Program
News Preview
Believes the Board Should Immediately Resume and Accelerate Buybacks
Asserts Board Should Remove Moshe Mizrahy as CEO of the Company
MIAMI, May 9, 2025 /PRNewswire/ -- DOMA Perpetual Capital Management LLC, a significant stockholder of InMode Ltd. (NYSE: INMD) ("InMode"), today sent a letter to the Board of Directors of InMode (the "Board") urgi...
Themefolio
Profiler
Peergroup
© PR Newswire
07.05.2025
INMD
LISTED
NASDAQ
InMode to Present at Upcoming Investor Conferences and Events
News Preview
YOKNEAM, Israel, May 7, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation at the following investor conferences:
BNP 3rd Annual Aesthetics Day
Presenters: Moshe Mizrahy, Chief Executive Officer and Yair Malca, Chief Financial Officer
Format: Virtual f...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
06.05.2025
INMD
LISTED
NASDAQ
InMode Granted Injunction Against Counterfeit Sales of Morpheus8 Radio Frequency Microneedling Devices and Needle Cartridges
News Preview
IRVINE, Calif., May 6, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, reports that the US District Court for the Central District of California granted InMode's motion for default judgment against the DHGate sellers and awarded InMode a permanent injunction and damages for the defend...
Themefolio
Profiler
Peergroup
© PR Newswire
28.04.2025
INMD
LISTED
NASDAQ
InMode Reports First Quarter 2025 Financial Results; Quarterly Revenue of $77.9 Million Represents 3% Year-Over-Year Decrease
News Preview
In April 2025, Completed Recent Share Repurchase Program of 6.95 Million Shares
YOKNEAM, Israel, April 28, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the first quarter ended March 31, 2025.
First Quarter 2025 Hig...
Themefolio
Profiler
Peergroup
© PR Newswire
14.04.2025
INMD
LISTED
NASDAQ
InMode to Report First Quarter 2025 Financial Results and Hold Conference Call on April 28, 2025, Expects Q1 Revenue Between $77.2M-$77.5M, Reiterates FY 2025 Revenue Guidance Between $395M-$405M
News Preview
Conference call to be held on Monday, April 28, 2025, at 8:30 a.m. Eastern Time
YOKNEAM, Israel, April 14, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results for the first quarter 2025 before the Nasdaq market opens on M...
Themefolio
Profiler
Peergroup
© PR Newswire
26.03.2025
INMD
LISTED
NASDAQ
InMode to Present at the 24th Annual Needham Virtual Healthcare Conference
News Preview
YOKNEAM, Israel, March 26, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Moshe Mizrahy, Chief Executive Officer, and Yair Malca, Chief Financial Officer, will present at the 24th Annual Needham Virtual Healthcare Conference on April 8, 2025.
The fireside chat,...
Themefolio
Profiler
Peergroup
© PR Newswire
06.03.2025
INMD
LISTED
NASDAQ
InMode Responds to Doma Perpetual's Letters
News Preview
Clarifies Capital Allocation Strategy and Commitment to Shareholder Returns
Refutes Misconceptions on Staffing and Production
Asserts No Justification for Additional Legal Action
YOKNEAM, Israel, March 6, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today sent a letter t...
Themefolio
Profiler
Peergroup
© PR Newswire
03.03.2025
INMD
LISTED
NASDAQ
InMode to Present at Upcoming Investor Conferences
News Preview
YOKNEAM, Israel, March 3, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation at the following investor conferences in March:
Barclays 27th Annual Global Healthcare Conference
Presenters: Yair Malca, Chief Financial Officer
Format: In-person fireside ch...
Themefolio
Profiler
Peergroup
© PR Newswire
04.02.2025
INMD
LISTED
NASDAQ
InMode Reports Fourth Quarter and Full Year 2024 Financial Results; Board of Directors Has Approved a New Share Repurchase Program
News Preview
Quarterly GAAP revenues of $97.9 million and full year revenue of $394.8 million
Returned $285.4 million of capital to shareholders in full year 2024
Together with new 10% program, represents repurchase of approximately 27% of shares outstanding within 15 month timeframe, with the potential of substantial additional capital return in 2025
YOKNEA...
Themefolio
Profiler
Peergroup
© PR Newswire
16.01.2025
INMD
LISTED
NASDAQ
InMode to Report Fourth Quarter & Full Year 2024 and Hold Conference Call on February 4, 2025, Earlier than Originally Announced
News Preview
Conference call rescheduled to Tuesday, February 4, 2025, at 8:30 a.m. Eastern Standard Time
YOKNEAM, Israel, Jan. 16, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it has adjusted the date for its fourth quarter and full year 2024 earnings conference call to an...
Themefolio
Profiler
Peergroup
© PR Newswire
15.01.2025
INMD
LISTED
NASDAQ
DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Immediately Execute Tender Offer followed by Share Buyback
News Preview
Believes the Board Must Immediately Execute a Tender Offer for 30% of the Company
Lays Out Action Plan to Restore Investor Confidence, Including an additional 10% Share Buyback in 2025
Announces Intent to Fight for Shareholders Should InMode Not Take Appropriate Action
MIAMI, Jan. 15, 2025 /PRNewswire/ -- DOMA Perpetual Capital Management LLC, a...
Themefolio
Profiler
Peergroup
© PR Newswire
08.01.2025
INMD
LISTED
NASDAQ
InMode to Report Fourth Quarter & Full Year 2024 Financial Results and Hold Conference Call on February 6, 2025, Expects Q4 Revenue Between $97.0M-$97.5M
News Preview
Conference call to be held on Thursday, February 6, 2025, at 8:30 a.m. Eastern Standard Time
YOKNEAM, Israel, Jan. 8, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results for the fourth quarter and full year 2024 before the N...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2024
INMD
LISTED
NASDAQ
InMode to Present at Upcoming Investor Conferences
News Preview
YOKNEAM, Israel, Nov. 6, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation at the following investor conferences in November and December:
UBS Global Healthcare ConferencePresenters: Yair Malca, Chief Financial OfficerFormat: In-person fireside chat mo...
Themefolio
Profiler
Peergroup
© PR Newswire
24.10.2024
INMD
LISTED
NASDAQ
InMode Granted Preliminary Injunction Against Online Sellers Prohibiting Counterfeit Sales of Morpheus8 Radiofrequency Devices and Cartridge Accessories
News Preview
IRVINE, Calif., Oct. 24, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, has been granted a preliminary injunction by the U.S. District Court for the Central District of California in a lawsuit filed against sellers identified to be the source of unlawful counterfeit sales of Morphe...
Themefolio
Profiler
Peergroup
© PR Newswire
10.10.2024
INMD
LISTED
NASDAQ
InMode to Report Third Quarter 2024 Financial Results and Hold Conference Call on October 30, 2024
News Preview
Expects Q3 Revenue Between $130.0 Million -$130.1 Million (including $31.9 Million in Revenue from First Half of 2024 Pre-orders), Decreases Full Year 2024 Guidance to $410 Million-$420 Million
Conference call to be held on Wednesday, October 30, 2024, at 8:30 a.m. Eastern Time
YOKNEAM, Israel, Oct. 10, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: I...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2024
INMD
LISTED
NASDAQ
InMode Announces Departures of President of North America, Chief Medical Officer and VP of Sales USA as Part of a Global Reorganization Strategy
News Preview
YOKNEAM, Israel, Oct. 1, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies today announced the departure of Shakil Lakhani, President of North America effective September 30, 2024. His departure follows that of Dr. Spero Theodorou, Chief Medical Officer, and Dan Wilson, VP of Sales USA....
Themefolio
Profiler
Peergroup
© PR Newswire
10.09.2024
INMD
LISTED
NASDAQ
InMode Announces Share Repurchase Program of Up to 7.68 Million Shares
News Preview
YOKNEAM, Israel, Sept. 10, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that its Board of Directors has approved a share repurchase program of up to 7.68 million ordinary shares....
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2024
INMD
LISTED
NASDAQ
InMode to Present at 2024 Baird Global Healthcare Conference
News Preview
YOKNEAM, Israel, Sept. 4, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Yair Malca, Chief Financial Officer will present in-person at the 2024 Baird Global Healthcare Conference in New York on Sept. 10, 2024.
The fireside chat, moderated by Jeff Johnson, Se...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
